Rosetta Genomics Ltd. (USA) operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Rosetta Genomics Ltd. (USA) with three other
pharmaceutical manufacturers in Middle East:
October Pharma For Pharmaceutical Industries SAE
of EGYPT
(2016
sales of 288.11 million Egyptian Pounds [US$18.42 million]
),
Hayat Pharmaceutical Industries Company PSC
of JORDAN
(10.54 million Jordanian Dinars [US$14.86 million]
), and
Philadelphia Pharmaceuticals Industry Company PSC
which is
also
based in JORDAN
(6.80 million Jordanian Dinars [US$9.59 million]
).
Sales Analysis.
Rosetta Genomics Ltd. (USA) reported sales of 35.31 million Israel Shekels (US$10.80 million)
for the
year ending
December of 2016.
This
represents
an
increase of 9.9%
versus 2015, when the company's sales were 32.13 million Israel Shekels.
Sales at Rosetta Genomics Ltd. (USA) have increased during each of the previous five years
(and since 2011, sales have increased a total of 9,497%).